Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

ATM deletion

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

ATM deletion	Bladder Cancer	ATM deletion	Bladder Cancer	M3814 Sensitive: D – Preclinical Sci Adv - 1 week (New D) M3814 Sensitive : D Sci Adv - 1wk	M3814 Sensitive: D – Preclinical Sci Adv - 1 week M3814 Sensitive : D Sci Adv - 1 week - (New D)
ATM deletion	Bladder Cancer	ATM deletion	Bladder Cancer	M6620 Sensitive: D – Preclinical Sci Adv - 1 week (New D) M6620 Sensitive : D Sci Adv - 1wk	M6620 Sensitive: D – Preclinical Sci Adv - 1 week M6620 Sensitive : D Sci Adv - 1 week - (New D)
ATM deletion	Bladder Cancer	ATM deletion	Bladder Cancer	PARP inhibitor Sensitive: D – Preclinical Sci Adv - 1 week (New D) PARP inhibitor Sensitive : D Sci Adv - 1wk	PARP inhibitor Sensitive: D – Preclinical Sci Adv - 1 week PARP inhibitor Sensitive : D Sci Adv - 1 week - (New D)
ATM deletion	Small Cell Lung Cancer	ATM deletion	Small Cell Lung Cancer	olaparib Sensitive: C2 – Inclusion Criteria olaparib Sensitive : C2	olaparib Sensitive: C2 – Inclusion Criteria olaparib Sensitive : C2
ATM deletion	Solid Tumor	ATM deletion	Solid Tumor	BAY 1895344 Sensitive: C2 – Inclusion Criteria BAY 1895344 Sensitive : C2	BAY 1895344 Sensitive: C2 – Inclusion Criteria BAY 1895344 Sensitive : C2
ATM deletion	Colorectal Cancer	ATM deletion	Colorectal Cancer	M6620 Sensitive: C3 – Early Trials M6620 Sensitive : C3	M6620 Sensitive: C3 – Early Trials M6620 Sensitive : C3
ATM deletion	Prostate Cancer	ATM deletion	Prostate Cancer	olaparib Sensitive: C3 – Early Trials olaparib Sensitive : C3	olaparib Sensitive: C3 – Early Trials olaparib Sensitive : C3
ATM deletion	Lung Adenocarcinoma	ATM deletion	Lung Adenocarcinoma	olaparib + VE-821 Sensitive: D – Preclinical olaparib + VE-821 Sensitive : D	olaparib + VE-821 Sensitive: D – Preclinical olaparib + VE-821 Sensitive : D
ATM deletion	Squamous Cell Carcinoma of Head and Neck	ATM deletion	Squamous Cell Carcinoma of Head and Neck	olaparib + AZD7648 Sensitive: D – Preclinical olaparib + AZD7648 Sensitive : D	olaparib + AZD7648 Sensitive: D – Preclinical olaparib + AZD7648 Sensitive : D
ATM deletion	Solid Tumor	ATM deletion	Solid Tumor	PLX038 Sensitive: D – Preclinical PLX038 Sensitive : D	PLX038 Sensitive: D – Preclinical PLX038 Sensitive : D
ATM deletion	Mantle Cell Lymphoma	ATM deletion	Mantle Cell Lymphoma	VP-006 Sensitive: D – Preclinical VP-006 Sensitive : D	VP-006 Sensitive: D – Preclinical VP-006 Sensitive : D
ATM deletion	Mantle Cell Lymphoma	ATM deletion	Mantle Cell Lymphoma	ART558 Sensitive: D – Preclinical ART558 Sensitive : D	ART558 Sensitive: D – Preclinical ART558 Sensitive : D